Home
Conditions
Laryngeal Neoplasms

Clinical trial condition

Laryngeal Neoplasms

Explore clinical trials studying Laryngeal Neoplasms. Study availability and eligibility vary by location and protocol.

180 public trials 45 recruiting studies

Refine in advanced search Browse all conditions

Laryngeal Neoplasms trial results

Recruiting

Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer

NCT06532279

Conditions: Carcinoma, Carcinoma, Squamous Cell, Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, +62 more
Locations: Arizona Center for Cancer Care - Gilbert Gilbert, Arizona, United States

Arizona Center for Cancer Care-Peoria Peoria, Arizona, United States

Arizona Center for Cancer Care - Phoenix Phoenix, Arizona, United States

Arizona Center for Cancer Care - Scottsdale Scottsdale, Arizona, United States

View all 153 locations

View Trial Details

Recruiting

Comparing Radiation Plus Cetuximab to Radiation Plus Chemotherapy in People With Head and Neck Cancer Who Cannot Receive Cisplatin

NCT07441681

Conditions: Carcinoma, Carcinoma, Squamous Cell, Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, +34 more
Locations: Tower Cancer Research Foundation Beverly Hills, California, United States

USC / Norris Comprehensive Cancer Center Los Angeles, California, United States

Cedars-Sinai Medical Center Los Angeles, California, United States

Helen F Graham Cancer Center Newark, Delaware, United States

View all 63 locations

View Trial Details

Recruiting

Remote Audiometry to Monitor for Treatment-Related Hearing Loss in Patients With H&N SCC Receiving Cisplatin and/or Radiation

NCT06662058

Conditions: Carcinoma, Carcinoma, Squamous Cell, Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, +54 more
Locations: Emory Midtown University Hospital/Winship Cancer Institute Atlanta, Georgia, United States

View Trial Details

Recruiting

Association Between Health Care Provider (HCP)-Assessed ECOG Performance Status (PS) and Overall Survival, and Objectively Measure of Physical Activity (PA) Levels in Advance-cancer Patients"

NCT01365169

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Islet Cell, +89 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Recruiting

Integrated Cancer Repository for Cancer Research

NCT02012699

Conditions: Abdominal Neoplasms, Adenoma, Adenomatous Polyposis Coli, +195 more
Locations: Advent Health Greenwood Village, Colorado, United States

Hartford HealthCare Cancer Institute at Manchester Medical Hospital Manchester, Connecticut, United States

Florida Hospital Memorial Medical Center Daytona Beach, Florida, United States

Florida Hospital DeLand DeLand, Florida, United States

View all 42 locations

View Trial Details

Recruiting

The Role of the Free/Pedunculated Flap in Total Laryngectomy After (Chemo-)Radiotherapy Failure for Laryngeal Carcinoma: Impact on the Risk of Pharyngocutaneous Fistula (PCF)

NCT06287034

Conditions: Head and Neck Neoplasms, Laryngeal Diseases, Laryngeal Neoplasms, +7 more
Locations: "Regina Elena" National Cancer Institute Rome, Italy

View Trial Details

Recruiting

Methotrexate, Erlotinib, and Celecoxib for the Treatment of Recurrent/Metastatic Head and Neck Cancer in a Rural Midwest United States Population

NCT06997068

Conditions: Carcinoma, Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Head and Neck Cancer, +34 more
Locations: Mayo Clinic in Rochester Rochester, Minnesota, United States

View Trial Details

Recruiting

Lymphocyte-Sparing And Radio-Immunotherapy in Head and Neck Carcinoma

NCT06706401

Conditions: Head and Neck Neoplasms, Hypopharyngeal Neoplasms, Hypopharynx Cancer, +15 more
Locations: Centre Léon Bérard Lyon, France

Institut de Cancérologie de Lorraine Vandœuvre-lès-Nancy, France

Institut Gustave Roussy Villejuif, France

Institut de Cancérologie de l'Ouest - Paul Papin Angers, France

View Trial Details

Recruiting

Neoadjuvant Chemotherapy and Programmed Cell Death Protein 1(PD-1) Inhibition for Head and Neck Cancer Treatment De-escalation (NeoScorch HN)

NCT07209189

Conditions: Carcinoma, Carcinoma, Squamous Cell, Communicable Diseases, +39 more
Locations: Johns Hopkins Hospital East Baltimore Baltimore, Maryland, United States

View Trial Details

Recruiting

Blood Tests and Questionnaires in Studying Adherence to Preventative Swallowing Exercises in Participants With Metastatic Head and Neck Cancer

NCT03010150

Conditions: Carcinoma, Carcinoma of Unknown Primary, Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, +53 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Laryngeal Neoplasms

Laryngeal Neoplasms trial results

Related conditions